News from Monday, February 24, 2025
Articles
SGLT-2 Inhibitors Show Similar Cardiovascular Benefits in T2D
(2/24, Lisa Kuhns, PhD, Renal & Urology News) reports “Canagliflozin and dapagliflozin demonstrate comparable overall cardiovascular effectiveness to empagliflozin, but low-dose dapagliflozin is associated with reduced effectiveness in preventing heart failure hospitalization, according to study results published in JAMA Internal Medicine.” Full
Cross-Atlantic Alliance Sets Sights on First HTA Methods Recommendations
(2/24, Francesca Bruce, Pink Sheet) reports “...HEMA, the Health Economics Methods Advisory, a recently announced collaboration between health technology appraisal (HTA) bodies in the US (ICER), England and Wales (NICE) and Canada (the CDA), is a step closer to developing important recommendations on methods and processes that could influence how appraisals are conducted.” Subscription Required
Press Releases
Telemedicine Adoption Leads to Fewer Low-Value Medical Tests
(2/24, Mass General Brigham Press Release) “...Compared to patients in low-telemedicine systems, patients in high-telemedicine systems had slightly higher rates of total visits (including virtual or in-person) and lower use of 7 of 20 low-value tests...The findings suggest that while virtual options may reduce barriers to care, telemedicine may also deter clinicians and patients from completing some low-value tests, especially tests like electrocardiograms and blood counts that would be done on-site during or just after an office visit.” Full
Journals
Comparative Effectiveness and Safety of Tislelizumab Versus Other Anti-PD-(L)1 Agents in First- and Subsequent Lines in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Systematic Literature Review and Network Meta-Analysis
Nicolas Girard, et al.
February 17, 2025, Lung Cancer
Comparative Effectiveness and Safety of Nifedipine and Magnesium Sulfate as Treatment Options for Preterm Birth: A Systematic Review and Meta-Analysis
Jianing Fan, et al.
February 22, 2025, BMJ Open
Patient Preference Effects in a Randomized Comparative Effectiveness Study of Electroconvulsive Therapy and Ketamine for Treatment Resistant Depression: An ELEKT-D Trial Secondary Analysis
Gerard Sanacora, et al.
February 23, 2025, Psychiatry Research
Stakeholders' Perspectives Toward the Use of Patient Registry Data for Decision-Making on Medicines: A Cross-Sectional Survey
Fabian Windfuhr, et al.
February 23, 2025, Drug Safety
Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitors and Risk of Chronic Kidney Disease–Mineral and Bone Disorders in Patients with Type 2 Diabetes Mellitus and Stage 1–3 Chronic Kidney Disease
Daniel Hsiang-Te Tsai, et al.
February 24, 2025, Canadian Medical Journal Association
Telemedicine Adoption and Low-Value Care Use and Spending Among Fee-for-Service Medicare Beneficiaries
Ishani Ganguli, MD, MPH; Christopher Lim, BA; Nicholas Daley, AB; et al
February 24, 2025, JAMA Internal Medicine
Global Perspectives on Patient-Centered Outcomes: Advancing Patient-Centered Cancer Clinical Trials Globally
Cecilia Monge, et al.
March 2025, Journal of the National Cancer Institute